Form D · Other Health Care
Passage BIO, Inc.
Philadelphia, PA · CIK 0001787297
Offering snapshot reported Sep 6, 2019 · SEC filing
- Reported sold
- $110M Offering amount: $110M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 21, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 6, 2019 | Initial | $109,999,974 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-348117
Source: Form D, filed Sep 6, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carl Gordon | Director |
| Patrick Heron | Director |
| Saqib Islam | Director |
| Stephen Squinto | Director, Executive |
| Thomas Street Address 1 Woiwode | Director |
| Tadataka Yamada | Director, Executive, Promoter |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
Two Commerce Square 2001 Market Street, 28 Th Floor
Philadelphia, PA, 19103
Philadelphia, PA, 19103